APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gliquidone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gliquidone Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchGliquidone Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Gliquidone Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Gliquidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gliquidone Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Gliquidone Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Gliquidone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gliquidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gliquidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gliquidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gliquidone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gliquidone market include Boehringer Ingelheim, Dexa Medica, Menarini Belgium, CR Double-Crane, Jinheng Pharma, Vanguard Pharma, Yiling Pharma and TIPR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gliquidone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gliquidone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gliquidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gliquidone market size, projected growth trends, production technologies, key applications, and end-use industries.

Gliquidone Segment by Company

Boehringer Ingelheim

Dexa Medica

Menarini Belgium

CR Double-Crane

Jinheng Pharma

Vanguard Pharma

Yiling Pharma

TIPR

Gliquidone Segment by Type

Glequinone Tablets

Glequinone Capsule

Glequinone Sustained Release Tablets

Others

Gliquidone Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Gliquidone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gliquidone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gliquidone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gliquidone significant trends, drivers, influence factors in global and regions.

6. To analyze Gliquidone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gliquidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gliquidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gliquidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gliquidone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gliquidone industry.

Chapter 3: Detailed analysis of Gliquidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gliquidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gliquidone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gliquidone Industry Trends Table 2. Gliquidone Industry Drivers Table 3. Gliquidone Industry Opportunities and Challenges Table 4. Gliquidone Industry Restraints Table 5. Global Gliquidone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gliquidone Revenue Share by Company (2021-2026) Table 7. Global Gliquidone Sales Volume by Company (kg) & (2021-2026) Table 8. Global Gliquidone Sales Volume Share by Company (2021-2026) Table 9. Global Gliquidone Average Price (US$/kg) of Company (2021-2026) Table 10. Global Gliquidone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gliquidone Key Company Manufacturing Base & Headquarters Table 12. Global Gliquidone Company, Product Type & Application Table 13. Global Gliquidone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gliquidone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Glequinone Tablets Table 18. Significant Companies of Glequinone Capsule Table 19. Significant Companies of Glequinone Sustained Release Tablets Table 20. Significant Companies of Others Table 21. Global Gliquidone Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 22. Global Gliquidone Sales Volume by Type (2021-2026) & (kg) Table 23. Global Gliquidone Sales Volume by Type (2027-2032) & (kg) Table 24. Global Gliquidone Sales Volume Share by Type (2021-2026) Table 25. Global Gliquidone Sales Volume Share by Type (2027-2032) Table 26. Global Gliquidone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Gliquidone Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Gliquidone Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Gliquidone Sales Value Share by Type (2021-2026) Table 30. Global Gliquidone Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Pharmacies Table 32. Significant Companies of Online Pharmacies Table 33. Significant Companies of Retail Pharmacies Table 34. Global Gliquidone Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 35. Global Gliquidone Sales Volume by Application (2021-2026) & (kg) Table 36. Global Gliquidone Sales Volume by Application (2027-2032) & (kg) Table 37. Global Gliquidone Sales Volume Share by Application (2021-2026) Table 38. Global Gliquidone Sales Volume Share by Application (2027-2032) Table 39. Global Gliquidone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Gliquidone Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Gliquidone Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Gliquidone Sales Value Share by Application (2021-2026) Table 43. Global Gliquidone Sales Value Share by Application (2027-2032) Table 44. Global Gliquidone Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 45. Global Gliquidone Sales by Region (2021-2026) & (kg) Table 46. Global Gliquidone Sales Market Share by Region (2021-2026) Table 47. Global Gliquidone Sales by Region (2027-2032) & (kg) Table 48. Global Gliquidone Sales Market Share by Region (2027-2032) Table 49. Global Gliquidone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Gliquidone Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Gliquidone Sales Value Share by Region (2021-2026) Table 52. Global Gliquidone Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Gliquidone Sales Value Share by Region (2027-2032) Table 54. Global Gliquidone Market Average Price (US$/kg) by Region (2021-2026) Table 55. Global Gliquidone Market Average Price (US$/kg) by Region (2027-2032) Table 56. Global Gliquidone Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 57. Global Gliquidone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Gliquidone Sales by Country (2021-2026) & (kg) Table 59. Global Gliquidone Sales Market Share by Country (2021-2026) Table 60. Global Gliquidone Sales by Country (2027-2032) & (kg) Table 61. Global Gliquidone Sales Market Share by Country (2027-2032) Table 62. Global Gliquidone Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Gliquidone Sales Value Market Share by Country (2021-2026) Table 64. Global Gliquidone Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Gliquidone Sales Value Market Share by Country (2027-2032) Table 66. Boehringer Ingelheim Company Information Table 67. Boehringer Ingelheim Business Overview Table 68. Boehringer Ingelheim Gliquidone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 69. Boehringer Ingelheim Gliquidone Product Portfolio Table 70. Boehringer Ingelheim Recent Development Table 71. Dexa Medica Company Information Table 72. Dexa Medica Business Overview Table 73. Dexa Medica Gliquidone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Dexa Medica Gliquidone Product Portfolio Table 75. Dexa Medica Recent Development Table 76. Menarini Belgium Company Information Table 77. Menarini Belgium Business Overview Table 78. Menarini Belgium Gliquidone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Menarini Belgium Gliquidone Product Portfolio Table 80. Menarini Belgium Recent Development Table 81. CR Double-Crane Company Information Table 82. CR Double-Crane Business Overview Table 83. CR Double-Crane Gliquidone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. CR Double-Crane Gliquidone Product Portfolio Table 85. CR Double-Crane Recent Development Table 86. Jinheng Pharma Company Information Table 87. Jinheng Pharma Business Overview Table 88. Jinheng Pharma Gliquidone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Jinheng Pharma Gliquidone Product Portfolio Table 90. Jinheng Pharma Recent Development Table 91. Vanguard Pharma Company Information Table 92. Vanguard Pharma Business Overview Table 93. Vanguard Pharma Gliquidone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. Vanguard Pharma Gliquidone Product Portfolio Table 95. Vanguard Pharma Recent Development Table 96. Yiling Pharma Company Information Table 97. Yiling Pharma Business Overview Table 98. Yiling Pharma Gliquidone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Yiling Pharma Gliquidone Product Portfolio Table 100. Yiling Pharma Recent Development Table 101. TIPR Company Information Table 102. TIPR Business Overview Table 103. TIPR Gliquidone Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. TIPR Gliquidone Product Portfolio Table 105. TIPR Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Gliquidone Distributors List Table 109. Gliquidone Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Gliquidone Product Image Figure 2. Global Gliquidone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gliquidone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gliquidone Sales (2021-2032) & (kg) Figure 5. Global Gliquidone Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Gliquidone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Glequinone Tablets Image Figure 10. Glequinone Capsule Image Figure 11. Glequinone Sustained Release Tablets Image Figure 12. Others Image Figure 13. Global Gliquidone Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 14. Global Gliquidone Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Gliquidone Sales Volume Share by Type (2021-2032) Figure 16. Global Gliquidone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Gliquidone Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Gliquidone Sales Value Share by Type (2021-2032) Figure 19. Hospital Pharmacies Image Figure 20. Online Pharmacies Image Figure 21. Retail Pharmacies Image Figure 22. Global Gliquidone Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 23. Global Gliquidone Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Gliquidone Sales Volume Share by Application (2021-2032) Figure 25. Global Gliquidone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Gliquidone Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Gliquidone Sales Value Share by Application (2021-2032) Figure 28. Global Gliquidone Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 29. Global Gliquidone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Gliquidone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Gliquidone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Gliquidone Sales Value (2021-2032) & (US$ Million) Figure 33. North America Gliquidone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Gliquidone Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Gliquidone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Gliquidone Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Gliquidone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Gliquidone Sales Value (2021-2032) & (US$ Million) Figure 39. South America Gliquidone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Gliquidone Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Gliquidone Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Gliquidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Gliquidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Gliquidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Gliquidone Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Gliquidone Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Glequinone Tablets
  • Glequinone Capsule
  • Glequinone Sustained Release Tablets
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Boehringer Ingelheim
  • Dexa Medica
  • Menarini Belgium
  • CR Double-Crane
  • Jinheng Pharma
  • Vanguard Pharma
  • Yiling Pharma
  • TIPR

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gliquidone Sales Value (2021-2032)
  4. 1.2.2 Global Gliquidone Sales Volume (2021-2032)
  5. 1.2.3 Global Gliquidone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gliquidone Market Dynamics
  1. 2.1 Gliquidone Industry Trends
  2. 2.2 Gliquidone Industry Drivers
  3. 2.3 Gliquidone Industry Opportunities and Challenges
  4. 2.4 Gliquidone Industry Restraints
3 Gliquidone Market by Company
  1. 3.1 Global Gliquidone Company Revenue Ranking in 2025
  2. 3.2 Global Gliquidone Revenue by Company (2021-2026)
  3. 3.3 Global Gliquidone Sales Volume by Company (2021-2026)
  4. 3.4 Global Gliquidone Average Price by Company (2021-2026)
  5. 3.5 Global Gliquidone Company Ranking (2024-2026)
  6. 3.6 Global Gliquidone Company Manufacturing Base and Headquarters
  7. 3.7 Global Gliquidone Company Product Type and Application
  8. 3.8 Global Gliquidone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gliquidone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gliquidone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gliquidone Market by Type
  1. 4.1 Gliquidone Type Introduction
  2. 4.1.1 Glequinone Tablets
  3. 4.1.2 Glequinone Capsule
  4. 4.1.3 Glequinone Sustained Release Tablets
  5. 4.1.4 Others
  6. 4.2 Global Gliquidone Sales Volume by Type
  7. 4.2.1 Global Gliquidone Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Gliquidone Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Gliquidone Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Gliquidone Sales Value by Type
  11. 4.3.1 Global Gliquidone Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Gliquidone Sales Value by Type (2021-2032)
  13. 4.3.3 Global Gliquidone Sales Value Share by Type (2021-2032)
5 Gliquidone Market by Application
  1. 5.1 Gliquidone Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Gliquidone Sales Volume by Application
  6. 5.2.1 Global Gliquidone Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gliquidone Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Gliquidone Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Gliquidone Sales Value by Application
  10. 5.3.1 Global Gliquidone Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gliquidone Sales Value by Application (2021-2032)
  12. 5.3.3 Global Gliquidone Sales Value Share by Application (2021-2032)
6 Gliquidone Regional Sales and Value Analysis
  1. 6.1 Global Gliquidone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gliquidone Sales by Region (2021-2032)
  3. 6.2.1 Global Gliquidone Sales by Region: 2021-2026
  4. 6.2.2 Global Gliquidone Sales by Region (2027-2032)
  5. 6.3 Global Gliquidone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gliquidone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gliquidone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gliquidone Sales Value by Region (2027-2032)
  9. 6.5 Global Gliquidone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gliquidone Sales Value (2021-2032)
  12. 6.6.2 North America Gliquidone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gliquidone Sales Value (2021-2032)
  15. 6.7.2 Europe Gliquidone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gliquidone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gliquidone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gliquidone Sales Value (2021-2032)
  21. 6.9.2 South America Gliquidone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gliquidone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gliquidone Sales Value Share by Country, 2025 VS 2032
7 Gliquidone Country-level Sales and Value Analysis
  1. 7.1 Global Gliquidone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gliquidone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gliquidone Sales by Country (2021-2032)
  4. 7.3.1 Global Gliquidone Sales by Country (2021-2026)
  5. 7.3.2 Global Gliquidone Sales by Country (2027-2032)
  6. 7.4 Global Gliquidone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gliquidone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gliquidone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gliquidone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gliquidone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gliquidone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gliquidone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gliquidone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gliquidone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gliquidone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gliquidone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gliquidone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gliquidone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gliquidone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gliquidone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gliquidone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gliquidone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gliquidone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gliquidone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gliquidone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gliquidone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gliquidone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gliquidone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gliquidone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gliquidone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gliquidone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gliquidone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gliquidone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gliquidone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gliquidone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gliquidone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gliquidone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gliquidone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gliquidone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gliquidone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gliquidone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gliquidone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gliquidone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gliquidone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gliquidone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gliquidone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gliquidone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gliquidone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gliquidone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gliquidone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gliquidone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gliquidone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gliquidone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gliquidone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gliquidone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gliquidone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gliquidone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gliquidone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gliquidone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gliquidone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gliquidone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gliquidone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gliquidone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gliquidone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gliquidone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gliquidone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gliquidone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gliquidone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gliquidone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gliquidone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gliquidone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gliquidone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gliquidone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gliquidone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gliquidone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gliquidone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gliquidone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gliquidone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gliquidone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gliquidone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gliquidone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gliquidone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gliquidone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gliquidone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gliquidone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gliquidone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gliquidone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gliquidone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gliquidone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gliquidone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gliquidone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gliquidone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Gliquidone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Gliquidone Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Dexa Medica
  8. 8.2.1 Dexa Medica Company Information
  9. 8.2.2 Dexa Medica Business Overview
  10. 8.2.3 Dexa Medica Gliquidone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Dexa Medica Gliquidone Product Portfolio
  12. 8.2.5 Dexa Medica Recent Developments
  13. 8.3 Menarini Belgium
  14. 8.3.1 Menarini Belgium Company Information
  15. 8.3.2 Menarini Belgium Business Overview
  16. 8.3.3 Menarini Belgium Gliquidone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Menarini Belgium Gliquidone Product Portfolio
  18. 8.3.5 Menarini Belgium Recent Developments
  19. 8.4 CR Double-Crane
  20. 8.4.1 CR Double-Crane Company Information
  21. 8.4.2 CR Double-Crane Business Overview
  22. 8.4.3 CR Double-Crane Gliquidone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CR Double-Crane Gliquidone Product Portfolio
  24. 8.4.5 CR Double-Crane Recent Developments
  25. 8.5 Jinheng Pharma
  26. 8.5.1 Jinheng Pharma Company Information
  27. 8.5.2 Jinheng Pharma Business Overview
  28. 8.5.3 Jinheng Pharma Gliquidone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jinheng Pharma Gliquidone Product Portfolio
  30. 8.5.5 Jinheng Pharma Recent Developments
  31. 8.6 Vanguard Pharma
  32. 8.6.1 Vanguard Pharma Company Information
  33. 8.6.2 Vanguard Pharma Business Overview
  34. 8.6.3 Vanguard Pharma Gliquidone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Vanguard Pharma Gliquidone Product Portfolio
  36. 8.6.5 Vanguard Pharma Recent Developments
  37. 8.7 Yiling Pharma
  38. 8.7.1 Yiling Pharma Company Information
  39. 8.7.2 Yiling Pharma Business Overview
  40. 8.7.3 Yiling Pharma Gliquidone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Yiling Pharma Gliquidone Product Portfolio
  42. 8.7.5 Yiling Pharma Recent Developments
  43. 8.8 TIPR
  44. 8.8.1 TIPR Company Information
  45. 8.8.2 TIPR Business Overview
  46. 8.8.3 TIPR Gliquidone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 TIPR Gliquidone Product Portfolio
  48. 8.8.5 TIPR Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gliquidone Value Chain Analysis
  2. 9.1.1 Gliquidone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gliquidone Sales Mode & Process
  6. 9.2 Gliquidone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gliquidone Distributors
  9. 9.2.3 Gliquidone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst